The pipeline includes clinical and IND stage mono and multispecific antibodies that target immune-mediated inflammatory diseases.

Researchers say approach could be useful for both initial treatment of bladder cancer as well as treatment refractory subsets of tumors.

Researchers developed the first human antibody cocktail to completely protect against the lethal Nipah and Hendra virus infection in preclinical models.

This GEN Live show will bring together a panel of leading experts to break down the latest advances, innovations, and challenges shaping genome editing.

AI‑guided analysis surfaces a new CAR T target with multi‑cancer activity, as Penn researchers validate GPNMB‑directed CAR T cells in preclinical models.

Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life ...

The discussion covered plans to increase the agency's headcount and to expedite early through late-stage clinical development in the U.S.

Discoveries may help to explain why some bacteria are hard to eliminate, and also point to potential future approaches to improving antibiotic effectiveness.

Lonza and InduPro signed a licensing agreement to support the advancement of innovative antibody–drug conjugate (ADC) therapies. According to Lonza officials, the company, through one of its ...

Researchers say newly identified cholesterol control pathway is completely separate from anything targeted by existing drugs.